Evidence map›Paper›PMID 29285286›Full record

ArticleOncotarget2017

MutT-related proteins are novel progression and prognostic markers for colorectal cancer.

Jin Li, Cheng-Cheng Yang, Xin-Yuan Tian, Yun-Xuan Li, Ju Cui, Zhe Chen, Zhou-Lu Deng, Fu-Jun Chen, Hiroshi Hayakawa, Mutsuo Sekiguchi and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical Significance of NUDT1 (MTH1) Across Cancer Types.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Mitotic MTH1 Inhibitors in Treatment of Cancer.Cancer treatment and research · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Identification of NUDT5 Inhibitors From Approved Drugs.Frontiers in molecular biosciences · 2020
    Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Jin LiPeking University Fifth School of Clinical Medicine, Beijing Hospital, Beijing, P.R. China.
Cheng-Cheng YangSchool of Pharmacy, Wenzhou Medical University, Wenzhou, P.R. China.
Xin-Yuan TianPeking University Fifth School of Clinical Medicine, Beijing Hospital, Beijing, P.R. China.
Yun-Xuan LiSchool of Pharmacy, Wenzhou Medical University, Wenzhou, P.R. China.
Ju CuiThe MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, P.R. China.
Zhe ChenThe MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Beijing, P.R. China.
Zhou-Lu DengDepartment of General Surgery, China-Japan Friendship Hospital, Beijing, P.R. China.
Fu-Jun ChenDepartment of Anorectal Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, P.R. China.
Hiroshi HayakawaFrontier Research Center, Fukuoka Dental College, Fukuoka, Japan.
Mutsuo SekiguchiFrontier Research Center, Fukuoka Dental College, Fukuoka, Japan.
Jian-Ping CaiPeking University Fifth School of Clinical Medicine, Beijing Hospital, Beijing, P.R. China.
Beijing Hospital · CNFukuoka Dental College · JPPeking University · CNWenzhou Medical University · CNChina-Japan Friendship Hospital · CNFirst Affiliated Hospital of Jiamusi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutT-related proteins, including MTH1, MTH2, MTH3 and NUDT5, can effectively degrade 8-oxoGua-containing nucleotides. The MTH1 expression is elevated in many types of human tumors and MTH1 overexpression correlates with the tumor pathological stage and poor prognosis. However, the expression of other MutT-related proteins in human cancers remains unknown. The present study systematically investigated the expression of MTH1, MTH2, MTH3 and NUDT5 in human colorectal cancer to establish its clinical significance.

methodsAmounts of

resultsThe expression of MTH1, MTH2, MTH3 and NUDT5 was significantly higher in CRC cells and CRC tissues than normal cells and tissues, and this phenomenon was significantly associated with AJCC stage and lymph node metastasis of CRC specimens. CRC patients with high expression of MTH1, MTH2 or NUDT5 had an extremely poor overall survival after surgical resection. Notably, NUDT5 was an independent prognostic factor of CRC patients. We found that knockdown of MutT-related proteins inhibited CRC cell proliferation.

conclusionsWe showed for the first time that MutT-related proteins play an important role in CRC progression and prognosis. Further investigations are needed to elucidate the role of these proteins in CRC progression and their potential use for therapeutic targets.

Indexed as

clinical relevancecolorectal cancerMutT-related proteinsoxidized nucleotidesprognosis

Identifiers

PMID29285286
PMCPMC5739673
OpenAlexW2769805473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.